PRICE T ROWE ASSOCIATES INC /MD/ - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$29,804
-15.8%
1,011,627
-6.8%
0.00%
-20.0%
Q2 2023$35,403
-14.2%
1,085,313
-7.4%
0.01%
-16.7%
Q1 2023$41,245
-18.7%
1,172,029
+5.8%
0.01%
-25.0%
Q4 2022$50,762
-99.9%
1,107,861
+1.3%
0.01%
-11.1%
Q3 2022$52,978,000
+170.9%
1,093,447
+119.7%
0.01%
+350.0%
Q2 2022$19,556,000
+14.9%
497,739
+7.6%
0.00%0.0%
Q1 2022$17,024,000
+149.9%
462,483
+209.5%
0.00%
+100.0%
Q4 2021$6,811,000
+546.8%
149,439
+407.3%
0.00%
Q3 2021$1,053,000
+87.0%
29,457
+3.6%
0.00%
Q2 2021$563,000
-10.9%
28,441
+4.6%
0.00%
Q1 2021$632,000
+29.2%
27,180
+15.5%
0.00%
Q4 2020$489,000
-96.6%
23,526
-96.4%
0.00%
-100.0%
Q3 2020$14,292,000
+310.6%
660,154
+54.5%
0.00%
+100.0%
Q4 2017$3,481,000
-43.5%
427,148
+0.4%
0.00%0.0%
Q3 2017$6,166,000
-43.3%
425,258
-70.3%
0.00%
-66.7%
Q3 2013$10,866,000
-68.1%
1,431,573
-51.4%
0.00%
-40.0%
Q2 2013$34,106,0002,947,7160.01%
Other shareholders
CYTOKINETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders